- Nachrichtendetail
-
07.06.2024 15:05:41 - dpa-AFX: *BIOMARIN: STUDY ON ROCTAVIAN SHOWS LONG-TERM BLEED CONTROL & FACTOR VIII EXPRESSION
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BioMarin Pharmaceutical | 924801 | NASDAQ | 70,580 | 27.09.24 22:00:10 | +0,340 | +0,48% | 70,560 | 70,580 | 70,550 | 70,240 |
